The Overnight Picture

Monday is opening with more cross-asset movement than most full weeks deliver. SpaceX (SPCX) extended its Friday debut gains by 19% in premarket trading, anchoring a broadly positive tone in Nasdaq futures. Simultaneously, oil prices fell sharply overnight after the U.S. and Iran reached a memorandum of understanding to reopen the Strait of Hormuz — the narrow Persian Gulf chokepoint through which a substantial share of global seaborne oil flows. And yet, despite the crude selloff and lingering rate concerns, S&P 500 futures are pointing higher.

Asian markets responded positively to the Hormuz deal when it first crossed wires in earlier sessions. SoftBank Group surged more than 12% on the news, and U.S. chip stocks including NVDA, MU, and INTC rose in overnight trading as investors priced in a more stable geopolitical backdrop and the prospect of easing energy costs. European markets are tracking that optimism into the morning.

The premarket picture is unusually eventful. Three distinct stories — an IPO, a geopolitical deal, and a macro tug-of-war — are each large enough to dominate a normal trading day on their own.

Today's Key Themes

Theme 1: SpaceX price discovery. SPCX priced at a market capitalization of $2.1 trillion, surpassing every prior IPO record. The 19% premarket extension suggests institutional demand remains robust, but first-day price discovery after a surge of that magnitude is rarely clean. The stock's behavior once regular trading opens — particularly whether it holds premarket levels or gives back gains as early buyers take profits — will set the tone for how markets assess the listing's durability. The valuation reflects SpaceX's dominant position in commercial launch services and its satellite internet ambitions, but at $2.1 trillion, the margin for execution disappointment is thin.

Theme 2: Oil's new floor. Crude prices fell meaningfully on the U.S.-Iran deal, which includes provisions covering oil sanctions and military operations. The practical impact was already visible in earlier sessions: an LNG tanker chartered by India's Petronet, stranded for more than three months, transited the Strait of Hormuz shortly after the announcement. That's a real-world confirmation that the corridor is functional again, not just a diplomatic statement. The formal signing is scheduled for June 19, and markets will treat every day between now and then as a period of deal risk. Energy equities and oil-linked currencies face continued pressure if the agreement holds.

Theme 3: The macro tension. S&P 500 futures are climbing despite a backdrop that isn't uniformly supportive. Bond yields are rising — reflecting the market's view that interest rates may stay elevated for longer — which mechanically pressures equity valuations by raising the discount rate applied to future earnings. Softer inflation expectations are providing the offset. The oil price decline, if it feeds through to broader energy costs, could reinforce that disinflationary signal and give the Federal Reserve more room. But the sequencing matters: yields moving before inflation data confirms the trend is a pattern that has whipsawed markets repeatedly in 2026.

The Calendar

No major U.S. economic releases are scheduled for Monday, June 15. The session's agenda is driven by the stories already in motion rather than fresh data.

The Bank of Japan rate decision remains the week's primary scheduled macro catalyst. Markets are pricing in a 25 basis point hike — a quarter of a percentage point — and analysts are focused on whether the accompanying statement signals further tightening. A hawkish tone could strengthen the yen and ripple through global bond markets, given Japan's position as a major holder of U.S. Treasuries.

The formal U.S.-Iran signing is scheduled for June 19. Between now and then, any signals of friction or renegotiation will move crude immediately.

In healthcare, Pfizer (PFE) has initiated Phase 3 trials for its obesity drug candidate berobenatide following favorable Phase 2b tolerability data. No catalyst is scheduled for today, but the stock may see continued analyst attention as the obesity drug market — currently dominated by GLP-1 treatments from Novo Nordisk and Eli Lilly — remains one of the most closely watched in pharmaceuticals.

Meta Platforms (META) completed its operational separation from AI startup Manus, ending data sharing between the two companies after unwinding a $2 billion acquisition that faced opposition from Beijing. The story is largely resolved, but it adds to a broader pattern of geopolitical friction in cross-border technology M&A that investors in large-cap tech should continue to monitor.

Watch List

SPCX — Price action at the open. The 19% premarket gain is the headline, but the real signal is whether institutional buyers step in to support the stock once retail and early momentum traders are active. A sharp fade from premarket levels would be worth noting; a hold or extension would validate the listing's demand picture.

Crude oil — WTI and Brent. The Hormuz deal has already moved prices, but the magnitude of the decline and whether it stabilizes or accelerates through the session will determine how energy equities trade. Watch XLE as a proxy for sector-wide pressure.

Bond yields — the 10-year Treasury. The tension between rising yields and equity futures pointing higher is the core macro contradiction of this morning. If yields continue climbing through the session, the equity rally's durability becomes a question. A pullback in yields would remove that headwind.

META — The Manus unwind is complete, but the company's AI strategy now rests more heavily on internal development. Any analyst commentary on what the failed acquisition means for Meta's competitive positioning in agentic AI could move the stock.

PFE — Phase 3 initiation for berobenatide is a meaningful pipeline milestone. With GLP-1 competition intensifying, watch for any analyst revisions to Pfizer's long-term valuation that reference the obesity program as a catalyst.

The session opens with more moving parts than usual. The SpaceX debut will capture the most attention, but the oil market's response to the Hormuz deal — and whether it feeds into the inflation and rates narrative — may prove to be the more consequential story by the close.